Characteristics | Number (%) | |
---|---|---|
Sex | Male | 56 (69) |
Female | 25 (31) | |
Age (years) | ≤ 60 | 67 (83) |
> 60 | 14 (17) | |
Performance status | ECOG 0/1 | 54 (67) |
ECOG ≥ 2 | 25 (31) | |
Missing | 2 (2) | |
Extranodal involvement | < 2 | 29 (36) |
≥ 2 | 52 (64) | |
Serum LDH | Normal | 38 (47) |
Increased | 40 (49) | |
Missing | 3 (4) | |
Ann Arbor stage | I/II | 18 (22)/11 (13) |
III/IV | 7 (9)/45 (56) | |
B symptoms | Absence | 30 (37) |
Presence | 51 (63) | |
Bone marrow invasion | Absent | 68 (84) |
Present | 7 (9) | |
Not evaluated | 6 (7) | |
NK Prognostic Index | Group 1/2 | 3 (4)/12 (15) |
Group 3/4 | 21 (26)/42 (52) | |
Missing | 3 (4) | |
International Prognostic Index | Low/Low-intermediate | 22 (27)/19 (24) |
High-intermediate/High | 26 (32)/11 (13) | |
Missing | 3 (4) | |
Clinical presentation | GI manifestation | 55 (68) |
Non-GI manifestation | 26 (32) | |
Nasal involvement | Absence | 63 (78) |
Presence | 18 (22) |